NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Health & Medicine Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health & Medicine Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Bee Venom



Breast cancer, metastasis, growth reduced with i.v. bee venom therapy in murine model



September 1st, 2003

In a mouse breast cancer model, intravenous but not intradermal bee venom reduced metastasis to lung.

According to published research from Croatia, "The possible tumor growth-inhibiting and metastasis-inhibiting effects of bee venom in mice and in tumor cell cultures were studied. The tumor was a transplantable mammary carcinoma (MCa) of CBA mouse.

"Intravenous administration of bee venom to mice significantly reduced the number of metastases in the lung. However, subcutaneous administration of bee venom did not reduce the number of lung metastases, indicating that the antitumor effect of the venom could be highly dependent on the route of injection...


Source: Health & Medicine Week (2003-09-01)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login